Literature DB >> 32979134

A pilot feasibility randomized controlled trial adding behavioral counseling to supervised physical activity in prostate cancer survivors: behavior change in prostate cancer survivors trial (BOOST).

Linda Trinh1, Arthur F Kramer2,3, Kendrith Rowland4, Dominick A Strom5, Jaime N Wong5, Edward McAuley5,3.   

Abstract

The purpose of this study was to evaluate the feasibility of delivering a supervised physical activity program plus standard exercise counseling (PA + EC) versus a supervised physical activity plus motivationally-enhanced behavioral counseling (PA + BC) in prostate cancer survivors. Secondary outcomes included objectively assessed PA, quality of life, body composition, cardiorespiratory fitness, cognitive functioning, and physical function. Twenty-six prostate cancer survivors were randomized to a 12-week supervised PA program plus standard exercise counseling or a 12-week supervised PA plus behavioral counseling based on the Multi-Process Action Control framework. Feasibility was determined through enrolment rate, measurement completion rate, loss-to-follow-up, adherence to the intervention, adverse events, and program evaluation items assessing burden and satisfaction. Of the 26 prostate cancer survivors enrolled (Mage = 65.6 ± 6.8), 96% completed the intervention. Measurement completion rates for the study measures were 88.5%. Adherence to the supervised PA sessions was 92% (completed 11/12 supervised PA sessions) and 100% (completed 12/12 supervised PA sessions) in the PA + EC and PA + BC group, respectively. Adherence to the home-based PA sessions was 70% (completed 7/10 home-based sessions) and 90% (completed 9/10 home-based sessions) in the PA + EC and PA + BC group, respectively. Overall, prostate cancer survivors were highly satisfied with the intervention components and found it rewarding, useful for research helping others, and useful for them personally. The patterns in the secondary outcomes were consistent with a positive impact of the intervention, favoring the PA + BC group. Preliminary evidence suggests that adding behavioral counseling to supervised PA in prostate cancer survivors may be feasible and result in better adherence to PA compared to exercise counseling alone, although additional refinement is needed. A combination of supervised and home-based PA may be feasible for behavior change in the self-management of prostate cancer. The study is registered with http://ClinicalTrials.gov (ID NCT03191968).

Entities:  

Keywords:  Behavior change; Cognitive function; Multi-process action control framework; Physical activity; Prostate cancer survivors

Year:  2020        PMID: 32979134     DOI: 10.1007/s10865-020-00185-8

Source DB:  PubMed          Journal:  J Behav Med        ISSN: 0160-7715


  33 in total

1.  Enhancing treatment fidelity in health behavior change studies: best practices and recommendations from the NIH Behavior Change Consortium.

Authors:  Albert J Bellg; Belinda Borrelli; Barbara Resnick; Jacki Hecht; Daryl Sharp Minicucci; Marcia Ory; Gbenga Ogedegbe; Denise Orwig; Denise Ernst; Susan Czajkowski
Journal:  Health Psychol       Date:  2004-09       Impact factor: 4.267

2.  Estimating clinically meaningful changes for the Functional Assessment of Cancer Therapy--Prostate: results from a clinical trial of patients with metastatic hormone-refractory prostate cancer.

Authors:  David Cella; Michael B Nichol; David Eton; Joel B Nelson; Parvez Mulani
Journal:  Value Health       Date:  2008-07-18       Impact factor: 5.725

Review 3.  Exercise therapy across the prostate cancer continuum.

Authors:  J Antonelli; S J Freedland; L W Jones
Journal:  Prostate Cancer Prostatic Dis       Date:  2009-03-10       Impact factor: 5.554

4.  Effect of aerobic exercise on cancer-associated cognitive impairment: A proof-of-concept RCT.

Authors:  K L Campbell; J W Y Kam; S E Neil-Sztramko; T Liu Ambrose; T C Handy; H J Lim; S Hayden; L Hsu; A A Kirkham; C C Gotay; D C McKenzie; L A Boyd
Journal:  Psychooncology       Date:  2017-02-10       Impact factor: 3.894

5.  Physical activity and survival among men diagnosed with prostate cancer.

Authors:  Stephanie E Bonn; Arvid Sjölander; Ylva Trolle Lagerros; Fredrik Wiklund; Pär Stattin; Erik Holmberg; Henrik Grönberg; Katarina Bälter
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2014-12-19       Impact factor: 4.254

6.  A multicenter randomized trial of the effects of exercise dose and type on psychosocial distress in breast cancer patients undergoing chemotherapy.

Authors:  Kerry S Courneya; Donald C McKenzie; Karen Gelmon; John R Mackey; Robert D Reid; Yutaka Yasui; Christine M Friedenreich; Cynthia C Forbes; Linda Trinh; Diana Jespersen; Diane Cook; Carolyn Proulx; Evyanne Wooding; Lianne B Dolan; Roanne J Segal
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2014-03-05       Impact factor: 4.254

7.  Exercise Guidelines for Cancer Survivors: Consensus Statement from International Multidisciplinary Roundtable.

Authors:  Kristin L Campbell; Kerri M Winters-Stone; Joachim Wiskemann; Anne M May; Anna L Schwartz; Kerry S Courneya; David S Zucker; Charles E Matthews; Jennifer A Ligibel; Lynn H Gerber; G Stephen Morris; Alpa V Patel; Trisha F Hue; Frank M Perna; Kathryn H Schmitz
Journal:  Med Sci Sports Exerc       Date:  2019-11       Impact factor: 5.411

8.  Lifestyle changes for improving disease-specific quality of life in sedentary men on long-term androgen-deprivation therapy for advanced prostate cancer: a randomised controlled trial.

Authors:  Liam Bourke; Stephen Gilbert; Richard Hooper; Liz A Steed; Miland Joshi; Jim W F Catto; John M Saxton; Derek J Rosario
Journal:  Eur Urol       Date:  2013-10-04       Impact factor: 20.096

Review 9.  Exercise for Men with Prostate Cancer: A Systematic Review and Meta-analysis.

Authors:  Liam Bourke; Dianna Smith; Liz Steed; Richard Hooper; Anouska Carter; James Catto; Peter C Albertsen; Bertrand Tombal; Heather A Payne; Derek J Rosario
Journal:  Eur Urol       Date:  2015-11-26       Impact factor: 20.096

10.  Cardiorespiratory fitness and long-term survival in "low-risk" adults.

Authors:  Carolyn E Barlow; Laura F Defina; Nina B Radford; Jarett D Berry; Kenneth H Cooper; William L Haskell; Lee W Jones; Susan G Lakoski
Journal:  J Am Heart Assoc       Date:  2012-08-24       Impact factor: 5.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.